Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CD
3301
Chaince Digital Holdings
CD
$230M
| $307K | ﹤0.01% |
+79,651
| New | +$401K |
|
3302
Valhi
VHI
$464M
| $305K | ﹤0.01% |
18,903
| – | – |
|
|
NB
3303
NioCorp Developments
NB
$775M
| $304K | ﹤0.01% |
+130,262
| New | +$325K |
|
|
DRUG
3304
Bright Minds Biosciences
DRUG
$787M
| $303K | ﹤0.01% |
+11,604
| New | +$348K |
|
|
DEFT
3305
Defi Technologies
DEFT
$182M
| $303K | ﹤0.01% |
+104,602
| New | +$350K |
|
|
STLN
3306
Starling Oncology, Inc. Common Stock
STLN
$626M
| $302K | ﹤0.01% |
+147,534
| New | +$369K |
|
3307
Ascent Industries
ACNT
$141M
| $302K | ﹤0.01% |
+23,954
| New | +$305K |
|
|
LFT
3308
Lument Finance Trust
LFT
$36.3M
| $301K | ﹤0.01% |
136,284
+112,249
| +467% | +$283K |
|
3309
Nerdy
NRDY
$94M
| $300K | ﹤0.01% |
184,318
-45,911
| -20% | -$73.3K |
|
3310
Union Bankshares
UNB
$118M
| $300K | ﹤0.01% |
+11,253
| New | +$343K |
|
3311
CSP Inc
CSPI
$81M
| $299K | ﹤0.01% |
+23,087
| New | +$332K |
|
|
SUNS
3312
Sunrise Realty Trust
SUNS
$103M
| $298K | ﹤0.01% |
28,067
| – | – |
|
3313
Inhibikase Therapeutics
IKT
$393M
| $297K | ﹤0.01% |
+152,298
| New | +$298K |
|
|
SFBC
3314
Sound Financial Bancorp
SFBC
$110M
| $295K | ﹤0.01% |
+6,412
| New | +$319K |
|
3315
Clarus
CLAR
$147M
| $294K | ﹤0.01% |
84,722
-8,921
| -10% | -$30.2K |
|
3316
AudioEye
AEYE
$72.7M
| $293K | ﹤0.01% |
25,172
+193
| +0.8% | +$2.3K |
|
|
NMAX
3317
Newsmax Inc
NMAX
$1.11B
| $292K | ﹤0.01% |
+19,318
| New | +$506K |
|
3318
Pliant Therapeutics
PLRX
$65.6M
| $292K | ﹤0.01% |
251,365
-137,984
| -35% | -$195K |
|
3319
Future Fuel
FF
$278M
| $291K | ﹤0.01% |
74,906
+55
| +0.1% | +$221 |
|
3320
Protara Therapeutics
TARA
$221M
| $290K | ﹤0.01% |
95,774
+80,774
| +538% | +$279K |
|
3321
NI Holdings
NODK
$316M
| $290K | ﹤0.01% |
22,727
+72
| +0.3% | +$931 |
|
3322
Critical Metals Corp
CRML
$993M
| $289K | ﹤0.01% |
80,841
+63,535
| +367% | +$116K |
|
3323
CF Bankshares
CFBK
$231M
| $289K | ﹤0.01% |
+12,047
| New | +$276K |
|
3324
Smith-Midland
SMID
$151M
| $288K | ﹤0.01% |
8,575
-4,526
| -35% | -$138K |
|
3325
Inseego
INSG
$86.2M
| $288K | ﹤0.01% |
+34,899
| New | +$273K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.